Topic: What's New in Neurofibromatosis
Wednesday, February 24, 2021
7:45 AM - 9:00 AM
Pamela Trapane, M.D.
Professor, Department of Pediatrics, Division of Pediatric Genetics
Chief, Division of Pediatric Genetics
Community Physicians, Faculty, Residents/Fellows, Staff/Employees
Upon completion of the presentation, participants will be able to:
At the conclusion of this session, the participant should be able to:
1. List the clinical diagnostic criteria for NF1.
2. Discuss how to apply the AAP Clinical Care Guidelines for NF1 in a clinical setting.
3. Discuss the clinical utility of molecular genetic testing for NF1.
4. Identify patients with NF1 who may benefit from chemotherapeutic agents.
5. Discuss barriers to care for patients with NF1.
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the Activity.
Please call Tina Smith 904-476-6747 or Miguel Perez 904-248-8490 for any technical assistance.
(UPDATED) To receive CME credit you must watch the Webinar in its entirety and take the evaluation at the end.
Dr. Trapane has disclosed that she’s on the Speaker Bureau and content editor for MedStudy Pediatric Board Review. No one else in a position to control content has any financial relationships to disclose.
Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. No one else in a position to control content has any financial relationships to disclose.
For additional information, contact Laura Lowry (904) 633-4199 email@example.com.